Yong J. Shin

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Structural, Compositional, and Dielectric State Profiling in Label-Free Single-Cell Monitoring.

Structural, Compositional, and Dielectric State Profiling in Label-Free Single-Cell Monitoring.

Journal: Small methods
Published: February 27, 2026

Minimal Residual Disease in Oncology: From Cure to Longitudinal Patient Management.

Minimal Residual Disease in Oncology: From Cure to Longitudinal Patient Management.

Journal: Cancers
Published: February 25, 2026

Loss of ABCA3 disrupts lipid balance and leads to AMPK-dependent suppression of SREBP1 in glioblastoma stem cells.

Loss of ABCA3 disrupts lipid balance and leads to AMPK-dependent suppression of SREBP1 in glioblastoma stem cells.

Journal: Oncogene
Published: November 04, 2025

Establishment of Human Lung Cancer Organoids Using Small Biopsy and Surgical Tissues.

Establishment of Human Lung Cancer Organoids Using Small Biopsy and Surgical Tissues.

Journal: Cancers
Published: May 21, 2025

Retraction Note: Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastoma.

Retraction Note: Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastoma.

Journal: Nature cell biology
Published: January 17, 2025

Improved Drug-Response Prediction Model of APC Mutant Colon Cancer Patient-Derived Organoids for Precision Medicine.

Improved Drug-Response Prediction Model of APC Mutant Colon Cancer Patient-Derived Organoids for Precision Medicine.

Journal: Cancers
Published: October 04, 2023

Olaparib enhances sensitization of BRCA-proficient breast cancer cells to x-rays and protons.

Olaparib enhances sensitization of BRCA-proficient breast cancer cells to x-rays and protons.

Journal: Breast cancer research and treatment
Published: June 08, 2023

Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastoma.

Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastoma.

Journal: Nature cell biology
Published: March 21, 2023

Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5.

Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5.

Journal: Neoplasia (New York, N.Y.)
Published: November 16, 2022

The semaphorin 3A/neuropilin-1 pathway promotes clonogenic growth of glioblastoma via activation of TGF-β signaling.

The semaphorin 3A/neuropilin-1 pathway promotes clonogenic growth of glioblastoma via activation of TGF-β signaling.

Journal: JCI insight
Published: November 09, 2022

Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.

Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.

Journal: The Journal of clinical investigation
Published: October 12, 2020

Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.

Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.

Journal: The Journal of clinical investigation
Published: September 02, 2020
Showing 1-12 of 34

Last Updated: 09/26/2026